US EditionAstraZeneca to withdraw COVID vaccine globally as demand dips
- AstraZeneca reported a decrease in demand for the Vaxzevria vaccine due to the availability of new Covid variant-specific vaccines.
- Multiple COVID-19 vaccines tailored to specific variants have led to Vaxzervria not being manufactured or supplied anymore.
- AstraZeneca announced the global withdrawal of its COVID-19 vaccine on May 7, citing excess availability of updated vaccines.
Insights by Ground AI
Does this summary seem wrong?
244 Articles
244 Articles
All
Left
32
Center
71
Right
50
AstraZeneca withdraws its vaccine against Covid-19 due to falling demand
The British pharmaceutical giant AstraZeneca announced on Wednesday that it is withdrawing from sale its vaccine against Covid-19 Vaxzevria, one of the first to be released during the pandemic, due to the drop in demand. “Considering that multiple vaccines have been developed against Covid-19, there is an excess of updated vaccines” in the face of the different variants of the virus, “which translates into a drop in demand for Vaxzevria, which i…
·Washington, United States
Read Full Article
Coverage Details
Total News Sources244
Leaning Left32Leaning Right50Center71Last UpdatedBias Distribution46% Center
Bias Distribution
- 46% of the sources are Center
46% Center
L 21%
C 46%
R 33%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
